July 8, 2024
Investors

A post-pandemic ‘new normal’ matters more to investors than AI: Morning Brief

This is The Takeaway from today’s Morning Brief, which you can sign up to receive in your inbox every morning along with: The first half of 2024 left little doubt for investors — this is an AI-fueled market. With Big Tech companies accounting for the majority of both stock market gains and earnings growth in

Read More
Investors

Spruce Biosciences to Participate in May Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 01, 2024–(BUSINESS WIRE)–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will participate in two upcoming investor conferences taking place in May. The JMP

Read More
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. View more
Accept
Decline